Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1988 Sep;56(9):2363–2368. doi: 10.1128/iai.56.9.2363-2368.1988

Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies.

W L Goff 1, W C Davis 1, G H Palmer 1, T F McElwain 1, W C Johnson 1, J F Bailey 1, T C McGuire 1
PMCID: PMC259573  PMID: 3410541

Abstract

Three Babesia bovis merozoite surface proteins with relative molecular weights of 37,000, 42,000, and 60,000 were identified by indirect immunofluorescence of live merozoites and by immunoprecipitation of 125I-surface-labeled merozoite proteins with immune bovine sera and monoclonal antibodies. These proteins were clearly of parasite origin, as evidenced by immunoprecipitation of metabolically labeled [( 35S]methionine) merozoites from cultures with specific antimerozoite monoclonal antibodies. In addition, two other proteins were identified with these methods. An 85-kilodalton protein was considered to be of parasite origin based on fluorescence reactivity with a monoclonal antibody. However, this protein was not detected after immunoprecipitation of metabolically labeled parasites, and thus, the exact nature of its origin is equivocal. A fifth protein of 145 kilodaltons was detected by immunoprecipitation after metabolic labeling but was not directly apparent on the surfaces of live merozoites. Since merozoite surface proteins may be important in the induction of protective immunity, those identified here are candidates for vaccine studies.

Full text

PDF
2363

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Callow L. L. Vaccination against bovine babesiosis. Adv Exp Med Biol. 1977;93:121–149. doi: 10.1007/978-1-4615-8855-9_9. [DOI] [PubMed] [Google Scholar]
  2. Campbell G. H., Miller L. H., Hudson D., Franco E. L., Andrysiak P. M. Monoclonal antibody characterization of Plasmodium falciparum antigens. Am J Trop Med Hyg. 1984 Nov;33(6):1051–1054. doi: 10.4269/ajtmh.1984.33.1051. [DOI] [PubMed] [Google Scholar]
  3. Freeman R. R., Holder A. A. Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites. J Exp Med. 1983 Nov 1;158(5):1647–1653. doi: 10.1084/jem.158.5.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Goff W. L., Wagner G. G., Craig T. M., Long R. F. The bovine immune response to tick-derived Babesia bovis infection: serological studies of isolated immunoglobulins. Vet Parasitol. 1982 Nov;11(2-3):109–120. doi: 10.1016/0304-4017(82)90032-2. [DOI] [PubMed] [Google Scholar]
  5. Goff W. L., Yunker C. E. Babesia bovis: increased percentage parasitized erythrocytes in cultures and assessment of growth by incorporation of [3H]hypoxanthine. Exp Parasitol. 1986 Oct;62(2):202–210. doi: 10.1016/0014-4894(86)90024-x. [DOI] [PubMed] [Google Scholar]
  6. Goodger B. V., Commins M. A., Wright I. G., Mirre G. B. Babesia bovis: vaccination of cattle against heterologous challenge with fractions of lysate from infected erythrocytes. Z Parasitenkd. 1984;70(3):321–329. doi: 10.1007/BF00927818. [DOI] [PubMed] [Google Scholar]
  7. Howard R. F., Stanley H. A., Campbell G. H., Langreth S. G., Reese R. T. Two Plasmodium falciparum merozoite surface polypeptides share epitopes with a single Mr 185 000 parasite glycoprotein. Mol Biochem Parasitol. 1985 Oct;17(1):61–77. doi: 10.1016/0166-6851(85)90128-8. [DOI] [PubMed] [Google Scholar]
  8. Howard R. F., Stanley H. A., Campbell G. H., Reese R. T. Proteins responsible for a punctate fluorescence pattern in Plasmodium falciparum merozoites. Am J Trop Med Hyg. 1984 Nov;33(6):1055–1059. doi: 10.4269/ajtmh.1984.33.1055. [DOI] [PubMed] [Google Scholar]
  9. Kuttler K. L., Levy M. G., James M. A., Ristic M. Efficacy of a nonviable culture-derived Babesia bovis vaccine. Am J Vet Res. 1982 Feb;43(2):281–284. [PubMed] [Google Scholar]
  10. Kuttler K. L., Levy M. G., Ristic M. Cell culture-derived Babesia bovis vaccine: sequential challenge exposure of protective immunity during a 6-month postvaccination period. Am J Vet Res. 1983 Aug;44(8):1456–1459. [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Levy M. G., Ristic M. Babesia bovis: continuous cultivation in a microaerophilous stationary phase culture. Science. 1980 Mar 14;207(4436):1218–1220. doi: 10.1126/science.7355284. [DOI] [PubMed] [Google Scholar]
  13. Love J. N. Cryogenic preservation of Anaplasma marginale with Dimethyl sulfoxide. Am J Vet Res. 1972 Dec;33(12):2557–2560. [PubMed] [Google Scholar]
  14. McElwain T. F., Palmer G. H., Goff W. L., McGuire T. C. Identification of Babesia bigemina and Babesia bovis merozoite proteins with isolate- and species-common epitopes recognized by antibodies in bovine immune sera. Infect Immun. 1988 Jun;56(6):1658–1660. doi: 10.1128/iai.56.6.1658-1660.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McElwain T. F., Perryman L. E., Davis W. C., McGuire T. C. Antibodies define multiple proteins with epitopes exposed on the surface of live Babesia bigemina merozoites. J Immunol. 1987 Apr 1;138(7):2298–2304. [PubMed] [Google Scholar]
  16. McGuire T. C., Perryman L. E., Davis W. C. Analysis of serum and lymphocyte surface IgM of healthy and immunodeficient horses with monoclonal antibodies. Am J Vet Res. 1983 Jul;44(7):1284–1288. [PubMed] [Google Scholar]
  17. Montenegro-James S., Ristic M., Toro Benitez M., Leon E., Lopez R. Heterologous strain immunity in bovine babesiosis using a culture-derived soluble Babesia bovis immunogen. Vet Parasitol. 1985 Dec;18(4):321–337. doi: 10.1016/0304-4017(85)90067-6. [DOI] [PubMed] [Google Scholar]
  18. Montenegro-James S., Toro Benitez M., Leon E., Lopez R., Ristic M. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens. Parasitol Res. 1987;74(2):142–150. doi: 10.1007/BF00536025. [DOI] [PubMed] [Google Scholar]
  19. Perrin L. H., Dayal R. Immunity to asexual erythrocytic stages of Plasmodium falciparum: role of defined antigens in the humoral response. Immunol Rev. 1982;61:245–269. doi: 10.1111/j.1600-065x.1982.tb00379.x. [DOI] [PubMed] [Google Scholar]
  20. Perrin L. H., Merkli B., Gabra M. S., Stocker J. W., Chizzolini C., Richle R. Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys. J Clin Invest. 1985 May;75(5):1718–1721. doi: 10.1172/JCI111881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rovis L., Barbet A. F., Williams R. O. Characterisation of the surface coat of Trypanosoma congolense. Nature. 1978 Feb 16;271(5646):654–656. doi: 10.1038/271654a0. [DOI] [PubMed] [Google Scholar]
  22. Siddiqui W. A., Tam L. Q., Kan S. C., Kramer K. J., Case S. E., Palmer K. L., Yamaga K. M., Hui G. S. Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys. Infect Immun. 1986 Apr;52(1):314–318. doi: 10.1128/iai.52.1.314-318.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Siddiqui W. A., Tam L. Q., Kramer K. J., Hui G. S., Case S. E., Yamaga K. M., Chang S. P., Chan E. B., Kan S. C. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc Natl Acad Sci U S A. 1987 May;84(9):3014–3018. doi: 10.1073/pnas.84.9.3014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smith R. D., James M. A., Ristic M., Aikawa M., Vega y Murguia C. A. Bovine babesiosis: protection of cattle with culture-derived soluble Babesia bovis antigen. Science. 1981 Apr 17;212(4492):335–338. doi: 10.1126/science.7209532. [DOI] [PubMed] [Google Scholar]
  25. Timms P., Dalgliesh R. J., Barry D. N., Dimmock C. K., Rodwell B. J. Babesia bovis: comparison of culture-derived parasites, non-living antigen and conventional vaccine in the protection of cattle against heterologous challenge. Aust Vet J. 1983 Mar;60(3):75–77. doi: 10.1111/j.1751-0813.1983.tb05874.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES